- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06687447
The Effect of Two Methods Applied to Mothers on Insufficient Milk Perception, Breastfeeding Motivation, Fatigue, Anxiety
November 12, 2024 updated by: Büşra Nur GELDİ, T.C. ORDU ÜNİVERSİTESİ
The Effect of Oxytocin Massage and Reflexology Applied to Primiparous Mothers After Cesarean Section on Insufficient Milk Perception, Breastfeeding Motivation, Fatigue, Anxiety and Uterus Involution
Although the World Health Organization predicts the caesarean section rate to be 10-15%, the caesarean section rate in Turkey is 52%, more than three times the international standard.
It is very important to eliminate the physical and psychosocial problems experienced by women during this period, to encourage breastfeeding, and at the same time to protect and improve maternal health.
Maintaining the mother's well-being after cesarean section and supporting pharmacological treatment with non-pharmacological practices have an important place in nursing care.
Therefore, this study will examine the effects of oxytocin massage and reflexology applied to mothers in the post-cesarean period on the perception of insufficient milk, breastfeeding motivation, fatigue, anxiety and uterine involution.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Büşra Nur GELDİ
- Phone Number: +905344313248
- Email: busranurgeldi@gmail.com
Study Contact Backup
- Name: Nülüfer ERBİL
- Phone Number: +905358306357
- Email: nulurerbil@gmail.com
Study Locations
-
-
-
Giresun, Turkey, 28100
- Recruiting
- Büşra Nur GELDİ
-
Contact:
- Büşra Nur GELDİ
- Phone Number: +9005344313248
- Email: busranurgeldi@gmail.com
-
Contact:
- NÜLÜFER ERBİL
- Phone Number: +90535 830 63 57
- Email: nerbil@odu.edu.tr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Mothers who gave birth at the age of 18 and over
- The one who is married
- At least primary school graduate,
- Primiparous mothers who gave birth by cesarean section,
- Having a single, healthy newborn at full term,
- Those who did not experience any problems during pregnancy and the early postpartum period,
- The tissue integrity in the area to be applied is complete and healthy,
- Breastfeeding her baby after birth,
- The baby is healthy, has no problems with the sucking reflex and does not have any congenital anomalies,
- Women who agree to participate in the research will be included in the study.
Exclusion Criteria:
- Those who gave birth by cesarean section before the 37th week of pregnancy,
- Women who gave birth by cesarean section with combined anesthesia,
- Discharged before 36 hours after birth,
- Having chronic diseases such as heart disease, diabetes, hypertension,
- Those with infectious diseases, infections, open wounds, masses, fractures, dislocations, deformities, varicose veins, burns, eczema, hematomas, thrombophlebitis, deep vein thrombosis on the foot skin,
- Experiencing any postpartum complications,
- Their baby is not with their mother for any reason,
- Those who have received a psychiatric diagnosis such as anxiety and depression,
- Women who want to leave the research at any stage of the research
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Oxycotin Massage Group
The researcher will perform oxytocin massage to the fifth-sixth rib along the patient's spine.
|
Primiparous women will be visited 12 hours after cesarean delivery, women will be informed, verbal and written consent will be obtained from women who want to participate in the study, and pre-test data will be collected by the researcher.
The pre-test data of the research were it will be collected by face-to-face interview technique in approximately 25 minutes.
The height of the fundus part of the uterus will be measured with a tape measure.
The woman's physiological parameters will be measured by the researcher.
At this stage, the patient will receive an oxytocin massage for 10 minutes while in a sitting position.
One hour after the application (13th hour after cesarean section), the physiological parameters of the patients will be measured again by the researcher.
24 hours after the application (36 hours after cesarean section), the data of the patients will be collected again by the researcher and uterine involution and physiological parameters will be evaluated.
|
|
Active Comparator: Reflexology Group
The researcher will apply pressure in different ways to the reflex points on the patient's sole with her fingers.
|
Primiparous women will be visited 12 hours after cesarean delivery, women will be informed women who want to participate in the study, and pre-test data will be collected.
The pre-test data of the research were it will be collectedapproximately 25 minutes.
The height of the fundus part of the uterus will be measured with a tape measure.
The woman's physiological parameters will be measured.
In practice; The foot is first relaxed and warmed up with passive movements, then the sole of the foot is scanned with the thumb walking crawling technique.
The application will be applied first to the right foot for 10 minutes and then to the left foot for a total of 20 minutes.
One hour after the application (13th hour after cesarean section), the physiological parameters of the patients will be measured again.
24 hours after the application (36 hours after cesarean section), the data of the patients will be collected again and uterine involution and physiological parameters will be evaluated.
|
|
Other: Control Group
Patients in the control group will not undergo any intervention and will receive their routine care.
|
Primiparous women will be visited 12 hours after cesarean delivery, women will be informed, verbal and written consent will be obtained from women who want to participate in the study, and pre-test data will be collected by the researcher.
The pre-test data of the research were it will be collected by face-to-face interview technique in approximately 25 minutes.
The height of the fundus part of the uterus will be measured with a tape measure.
The woman's physiological parameters will be measured by the researcher.
Patients in the control group will not undergo any intervention and will receive their routine care.
One hour after the application (13th hour after cesarean section), the physiological parameters of the patients will be measured again by the researcher.
24 hours after the application (36 hours after cesarean section), the data of the patients will be collected again by the researcher and uterine involution and physiological parameters will be evaluated.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insufficient Milk Perception Scale
Time Frame: 36 hours
|
The Insufficient Milk Perception Scale consists of a total of 6 questions and a single subscale.
The first question on the scale is whether the mother finds her milk sufficient.
The first question is answered as yes or no.
The other 5 questions are scored between 0-10.
The given score indicates that as it approaches zero, the mother perceives her milk as inadequate, and as she approaches 10, she perceives enough.
A minimum of zero points and a maximum of 50 points can be obtained from the scale.
The high score indicates that milk is sufficiently perceived.
|
36 hours
|
|
Primipar Breastfeeding Motivation Scale
Time Frame: 36 hours
|
The Insufficient Milk Perception Scale consists of a total of 6 questions and a single subscale.
The first question on the scale is whether the mother finds her milk sufficient.
The first question is answered as yes or no.
The other 5 questions are scored between 0-10.
The given score indicates that as it approaches zero, the mother perceives her milk as inadequate, and as she approaches 10, she perceives enough.
A minimum of zero points and a maximum of 50 points can be obtained from the scale.
The high score indicates that milk is sufficiently perceived.
|
36 hours
|
|
Visual Similarity Scale for Fatigue (VAS-F)
Time Frame: 36 hours
|
The scale consists of 29 items and has a 7-point Likert type and 4 sub-dimensions.
These sub-dimensions; the value given to breastfeeding (items 1,2,4,6,8,10,12,14,15,20,24,25,28), self-efficacy (items 9,16,17,18,19,26,29 ), midwife support (items 21,22,23,27), success expectation (items 3,5,7,11,13).
As the score obtained from each sub-dimension increases, the breastfeeding motivation level of that sub-dimension increases.
|
36 hours
|
|
The State-Trait Anxiety Inventory (STAI)
Time Frame: 36 hours
|
The State-Trait Anxiety Inventory (STAI) is a commonly used measure of trait and state anxiety.
It can be used in clinical settings to diagnose anxiety and to distinguish it from depressive syndromes.
It also is often used in research as an indicator of caregiver distress.
Form has 20 items for assessing for state anxiety.
State anxiety items include: "I am tense; I am worried" and "I feel calm; I feel secure."
All items are rated on a 4-point scale (e.g., from "Almost Never" to "Almost Always").
Higher scores indicate greater anxiety.
|
36 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Uterine Involution Evaluation Form
Time Frame: 36 hours
|
This form is a form prepared by the researcher in line with the literature, in which the measurement of the length of the uterus is recorded and the uterine involution process of postpartum women is evaluated.
The length of the uterus; It will be done by measuring the distance between the fundus of the uterus and the symphysis pubis with the help of a tape measure.
When measuring uterine length, women will be ensured that their bladder is empty and the same tape measure will be used in all measurements.
|
36 hours
|
|
Physiological Parameters Evaluation Form
Time Frame: 36 hours
|
In this study, heart rate, body temperature, oxygen saturation, respiratory rate and blood pressure values will be measured and recorded in the Physiological Parameters Form.
|
36 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Büşra Nur GELDİ, T.C. ORDU ÜNİVERSİTESİ
- Study Director: Nülüfer ERBİL, T.C. ORDU ÜNİVERSİTESİ
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 6, 2023
Primary Completion (Estimated)
December 30, 2024
Study Completion (Estimated)
July 6, 2025
Study Registration Dates
First Submitted
December 28, 2023
First Submitted That Met QC Criteria
November 12, 2024
First Posted (Estimated)
November 13, 2024
Study Record Updates
Last Update Posted (Estimated)
November 13, 2024
Last Update Submitted That Met QC Criteria
November 12, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ODU-HSI-BNG-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Caesarean Section
-
Ashulia Women and Children HospitalCompleted
-
Assiut UniversityCompletedCaesarean SectionEgypt
-
Taipei Medical University WanFang HospitalCompletedCaesarean SectionTaiwan
-
South Tees Hospitals NHS Foundation TrustCompletedCaesarean Section | Caesarean Section; InfectionUnited Kingdom
-
Karamanoğlu Mehmetbey UniversityRecruitingCaesarean SectionTurkey (Türkiye)
-
Büşra KüçüktürkmenNot yet recruiting
-
Maimonides Medical CenterTerminatedCaesarean SectionUnited States
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentUnknownCaesarean SectionNetherlands
-
Sichuan Provincial People's HospitalNot yet recruiting
Clinical Trials on Oxycotin Massage Group
-
Ankara Yildirim Beyazıt UniversityNot yet recruiting
-
Western Oregon UniversityHRSA/Maternal and Child Health BureauCompleted
-
Western Oregon UniversityHRSA/Maternal and Child Health BureauCompleted
-
Amasya UniversityCompletedLabor Pain | Posttraumatic GrowthTurkey
-
Inonu UniversityCompletedNurse | Premature Newborn | Physiological MeasurementsTurkey
-
KTO Karatay UniversityCompletedBreast-feeding | Massage Effect | PrimiparityTurkey
-
Inonu UniversityCompleted
-
Chiayi Christian HospitalCompletedGrowth | Preterm Infants | MCT Oil MassageTaiwan
-
Istanbul Medipol University HospitalCompletedAnterior Cruciate Ligament Injuries | Vibration TherapyTurkey
-
University of YalovaCompletedHemodialysis Complication | Exercise Addiction | Nursing CariesTurkey (Türkiye)